CN1195852C - 可结合生物素的受体分子 - Google Patents

可结合生物素的受体分子 Download PDF

Info

Publication number
CN1195852C
CN1195852C CNB998032174A CN99803217A CN1195852C CN 1195852 C CN1195852 C CN 1195852C CN B998032174 A CNB998032174 A CN B998032174A CN 99803217 A CN99803217 A CN 99803217A CN 1195852 C CN1195852 C CN 1195852C
Authority
CN
China
Prior art keywords
leu
thr
glu
ser
asn
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CNB998032174A
Other languages
English (en)
Chinese (zh)
Other versions
CN1291230A (zh
Inventor
S·伊拉－赫图亚拉
M·库洛马
P·莱托拉南
V·马尔约马基
K·阿伦尼
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Ark Therapeutics Ltd
Original Assignee
Eurogene Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9803757.5A external-priority patent/GB9803757D0/en
Priority claimed from GBGB9813653.4A external-priority patent/GB9813653D0/en
Application filed by Eurogene Ltd filed Critical Eurogene Ltd
Publication of CN1291230A publication Critical patent/CN1291230A/zh
Application granted granted Critical
Publication of CN1195852C publication Critical patent/CN1195852C/zh
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/465—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from birds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biophysics (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • General Engineering & Computer Science (AREA)
  • Peptides Or Proteins (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CNB998032174A 1998-02-23 1999-02-23 可结合生物素的受体分子 Expired - Fee Related CN1195852C (zh)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9803757.5 1998-02-23
GBGB9803757.5A GB9803757D0 (en) 1998-02-23 1998-02-23 Fusion proteins
GB9813653.4 1998-06-24
GBGB9813653.4A GB9813653D0 (en) 1998-06-24 1998-06-24 Fusion proteins

Publications (2)

Publication Number Publication Date
CN1291230A CN1291230A (zh) 2001-04-11
CN1195852C true CN1195852C (zh) 2005-04-06

Family

ID=26313170

Family Applications (1)

Application Number Title Priority Date Filing Date
CNB998032174A Expired - Fee Related CN1195852C (zh) 1998-02-23 1999-02-23 可结合生物素的受体分子

Country Status (16)

Country Link
US (1) US7208291B2 (https=)
EP (1) EP1056850B1 (https=)
JP (1) JP2002504328A (https=)
KR (1) KR100722578B1 (https=)
CN (1) CN1195852C (https=)
AT (1) ATE274058T1 (https=)
AU (1) AU750444B2 (https=)
CA (1) CA2319039A1 (https=)
DE (1) DE69919515T2 (https=)
DK (1) DK1056850T3 (https=)
ES (1) ES2226340T3 (https=)
HU (1) HUP0101614A3 (https=)
NO (1) NO328139B1 (https=)
PL (1) PL195990B1 (https=)
PT (1) PT1056850E (https=)
WO (1) WO1999042577A2 (https=)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040209294A1 (en) * 2002-09-02 2004-10-21 National Food Research Institute Method to produce a receptor chip using biotinylated protein
US9623117B2 (en) * 2011-04-04 2017-04-18 Wisconsin Alumni Research Foundation Method for selective targeting and entry of bacterial toxins to cells
CN113354744A (zh) * 2013-12-20 2021-09-07 弗雷德哈钦森癌症研究中心 带标签的嵌合效应分子及其受体
EP3288570A4 (en) 2015-04-29 2018-11-21 Fred Hutchinson Cancer Research Center Modified stem cells and uses thereof

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4839293A (en) * 1986-02-24 1989-06-13 The Trustees Of Columbia University In The City Of New York DNA encoding streptavidin, streptavidin produced therefrom, fused polypeptides which include amino acid sequences present in streptavidin and uses thereof
US5135736A (en) * 1988-08-15 1992-08-04 Neorx Corporation Covalently-linked complexes and methods for enhanced cytotoxicity and imaging
CA1340977C (en) 1988-11-15 2000-04-25 Monty Krieger Scavenger receptor protein and antibody thereto
US5457035A (en) 1993-07-23 1995-10-10 Immunex Corporation Cytokine which is a ligand for OX40
US5846537A (en) 1995-06-07 1998-12-08 University Of Rochester Modified avidin and streptavidin and methods of use thereof
US6497881B1 (en) * 1995-11-30 2002-12-24 New York University High efficiency tissue specific compound delivery system using streptavidin-protein a fusion protein

Also Published As

Publication number Publication date
DE69919515D1 (de) 2004-09-23
JP2002504328A (ja) 2002-02-12
US20040185059A1 (en) 2004-09-23
HUP0101614A2 (hu) 2001-09-28
WO1999042577A3 (en) 1999-10-21
CA2319039A1 (en) 1999-08-26
PL343079A1 (en) 2001-07-30
DK1056850T3 (da) 2004-11-29
PT1056850E (pt) 2004-12-31
NO328139B1 (no) 2009-12-14
DE69919515T2 (de) 2005-04-07
KR20010085196A (ko) 2001-09-07
PL195990B1 (pl) 2007-11-30
ES2226340T3 (es) 2005-03-16
AU2631299A (en) 1999-09-06
EP1056850A2 (en) 2000-12-06
US7208291B2 (en) 2007-04-24
AU750444B2 (en) 2002-07-18
NO20004195L (no) 2000-08-22
EP1056850B1 (en) 2004-08-18
ATE274058T1 (de) 2004-09-15
CN1291230A (zh) 2001-04-11
KR100722578B1 (ko) 2007-05-28
HUP0101614A3 (en) 2006-04-28
WO1999042577A2 (en) 1999-08-26
NO20004195D0 (no) 2000-08-22

Similar Documents

Publication Publication Date Title
CN1178956C (zh) 基于癌抑制基因wt1的产物的癌抗原
CN1278183A (zh) 可溶性mhc复合体及其使用方法
CN1561343A (zh) 可溶性t细胞受体
CN1671423A (zh) 新型嵌合cd154
CN1277614A (zh) 乳房珠蛋白,一种乳房特异性乳腺癌分泌蛋白
HK1045528A1 (en) Neurotrophic growth factor
CN1222536C (zh) 肝细胞癌的预防及治疗
CN101062952A (zh) 由人血清白蛋白和干扰素组成的融合蛋白及其编码基因与应用
CN1195852C (zh) 可结合生物素的受体分子
CN1304421C (zh) 对病毒蛋白gp120有亲合性的肽及这些肽的应用
CN1256347C (zh) 激肽原第五结构域－肿瘤坏死因子相关凋亡诱导配体的融合蛋白及其制法和用途
CN1217023A (zh) 犬ob蛋白组合物和方法
CN1566342A (zh) Sars冠状病毒的s蛋白的抗原表位、其抗体、编码核酸以及含有它们的组合物
CN101039955A (zh) 与sars冠状病毒刺突蛋白相关的核酸、多肽、表达方法和免疫原性组合物
CN1159333C (zh) 旋毛虫抗原基因Ts87及其应用
CN1636013A (zh) 可编码hiv辅助蛋白的dna疫苗
CN1244595C (zh) 一种肿瘤抑制蛋白及其应用
CN1948333A (zh) 一种新的hPEBP4蛋白来源的HLA－A2限制性表位多肽及其应用
CN1621411A (zh) 一种用于治疗获得性免疫缺陷综合征的重组靶向融合蛋白
CN101037476A (zh) 一种用于制备抗体化乙肝疫苗的融合蛋白及其载体
CN1244375C (zh) 人肝再生相关蛋白及其应用
CN1300315C (zh) 奶牛之犊牛前胸腺素基因及其克隆方法与应用
CN1220701C (zh) 重组人外周淋巴组织趋化性细胞因子及其制备方法和用途
CN1233187A (zh) HIVp－17肽片段、含有该片段的组合物及其制造和使用方法
CN101058808A (zh) 一种与乳腺癌有关的p60基因,其编码的蛋白及应用

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C56 Change in the name or address of the patentee

Owner name: ARK THERAPEUTICS CO., LTD.

Free format text: FORMER NAME OR ADDRESS: EUROGENE LTD.

CP01 Change in the name or title of a patent holder

Address after: London, England

Patentee after: ARK THERAPEUTICS Ltd.

Address before: London, England

Patentee before: Eurogene Ltd.

C17 Cessation of patent right
CF01 Termination of patent right due to non-payment of annual fee

Granted publication date: 20050406

Termination date: 20120223